Hormones / antineoplastics

WPI 2233 Pill - white round, 10mm

Pill with imprint WPI 2233 is White, Round and has been identified as Tamoxifen Citrate 20 mg. It is supplied by Watson Pharmaceuticals, Inc.

Tamoxifen is used in the treatment of Breast Cancer, Adjuvant; Breast Cancer, Metastatic; Breast Cancer; Breast Cancer, Male; Breast Cancer, Palliative and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Tamoxifen (Tamoxifen [ ta-mox-i-fen ])-WPI 2233-20 mg-White-Round
Tamoxifen (Tamoxifen [ ta-mox-i-fen ])-WPI 2233-20 mg-White-Round
Tamoxifen (Tamoxifen [ ta-mox-i-fen ])-WPI 2233-20 mg-White-Round
Tamoxifen (Tamoxifen [ ta-mox-i-fen ])-WPI 2233-20 mg-White-Round
Tamoxifen (Tamoxifen [ ta-mox-i-fen ])-WPI 2233-20 mg-White-Round
Tamoxifen (Tamoxifen [ ta-mox-i-fen ])-WPI 2233-20 mg-White-Round

Tamoxifen
Generic Name: tamoxifen [ ta-mox-i-fen ]
Imprint: WPI 2233
Strength: 20 mg
Color: White
Size: 10.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Hormones / antineoplastics Selective estrogen receptor modulators
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00591-2233 (Discontinued)
Inactive Ingredients: Croscarmellose sodium, Lactose monohydrate, Magnesium stearate, Microcrystalline cellulose, Corn starch,
Latest News
Related Drugs